Q1 2020 Holdings
Filed 2020-05-15 | 53 holdings | $388.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $225.6M | 2,003,147 | 58.0% |
| Arcutis Biotherapeutics Inc(ARQT) | Common | 03969K108 | $50.3M | 1,686,527 | 12.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $48.8M | 3,320,801 | 12.6% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $22.1M | 768,674 | 5.7% |
| Codexis, Inc(CDXS) | Common | 192005106 | $16.7M | 1,493,903 | 4.3% |
| Collegium Pharmaceutical Inc(COLL) | Common | 19459J104 | $7.3M | 447,173 | 1.9% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $7.3M | 500,732 | 1.9% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $6.3M | 252,119 | 1.6% |
| Atricure Inc(ATRC) | Common | 04963C209 | $2.2M | 64,573 | 0.6% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $1.7M | 1,647,214 | 0.4% |
| New Frontier Health Corp | Common | G6461G106 | $118.0K | 14,300,000 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $52.5K | 12,539,515 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $39.1K | 1,101,236 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $38.2K | 5,900,000 | 0.0% |
| Forty Seven Inc(FTSVEUR) | Common | 34983P104 | $37.8K | 395,691 | 0.0% |
| Passage Bio Inc | Common | 702712100 | $35.1K | 2,229,587 | 0.0% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $28.4K | 3,575,424 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $22.0K | 888,724 | 0.0% |
| Verastem Inc | Common | 92337C104 | $21.5K | 8,139,535 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | Common | 816212104 | $18.9K | 7,846,509 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $18.8K | 1,917,074 | 0.0% |
| Akero Therapeutics Inc(AKRO) | Common | 00973Y108 | $17.1K | 808,247 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $16.6K | 6,492,247 | 0.0% |
| Karuna Therapeutics Inc | Common | 48576A100 | $16.1K | 223,692 | 0.0% |
| MEI Pharma Inc | Common | 55279B202 | $15.8K | 9,784,422 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $15.7K | 1,008,562 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $15.6K | 333,621 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | Common | 00739L101 | $14.0K | 5,118,560 | 0.0% |
| Orchard Therapeutics plc | ADS | 68570P101 | $12.3K | 1,627,225 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $12.2K | 1,791,257 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | Common | 77313F106 | $12.0K | 860,648 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $11.8K | 759,050 | 0.0% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $11.5K | 524,290 | 0.0% |
| Zai Lab Limited(ZLAB) | ADR | 98887Q104 | $11.4K | 222,107 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $11.3K | 1,476,796 | 0.0% |
| IGM Biosciences Inc(1K0) | Common | 449585108 | $11.2K | 199,626 | 0.0% |
| Avrobio Inc | Common | 05455M100 | $11.2K | 717,753 | 0.0% |
| Menlo Therapeutics Inc. | Common | 586858102 | $10.3K | 3,843,824 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $8.3K | 2,054,468 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $6.9K | 786,883 | 0.0% |
| Matinas Biopharma Hldgs Inc | Common | 576810105 | $6.8K | 11,279,323 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $6.2K | 1,492,951 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $4.8K | 2,021,377 | 0.0% |
| Chiasma Inc(CHMA) | Common | 16706W102 | $4.6K | 1,272,156 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $4.5K | 396,589 | 0.0% |
| Constellation Pharmaceutical(CNST) | Common | 210373106 | $4.4K | 140,298 | 0.0% |
| Revolution Medicines Inc(RVMD) | Common | 76155X100 | $4.4K | 199,518 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $3.0K | 860,103 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $1.6K | 1,077,467 | 0.0% |
| Uniqure NV(QURE) | Common | N90064101 | $1.1K | 22,932 | 0.0% |